Cargando…
Vasoactive intestinal peptide inhibits the production of Salmonella-induced inflammatory cytokines by human monocytes
Autores principales: | Askar, B, Barrow, P, Foster, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273770/ http://dx.doi.org/10.1186/cc14030 |
Ejemplares similares
-
Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
por: Petersen, Christopher, et al.
Publicado: (2015) -
Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016) -
Comparison of vasoactive medications and investigation determinants of mortality in children
por: Demirkol, D, et al.
Publicado: (2008) -
Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015) -
Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)